Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» DexCom: Revenue Up, EPS Misses Mark
DexCom: Revenue Up, EPS Misses Mark
DexCom: Revenue Up, EPS Misses Mark
Submitted by
admin
on February 14, 2025 - 9:37am
Source:
Motley Fool
News Tags:
DexCom
earnings
Medtech
CGMs
Headline:
DexCom: Revenue Up, EPS Misses Mark
snippet:
Revenue for Q4 2024 was $1.114 billion, marking an 8% increase year-over-year.
Non-GAAP EPS stood at $0.45, missing the estimated $0.50 and reflecting a 10% decline from Q4 2023.
Operating income (non-GAAP) decreased to $209.5 million from $242.7 million.
Do Not Allow Advertisers to Use My Personal information